These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9523225)

  • 1. Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy.
    Kantarjian HM; Giles FJ; O'Brien SM; Talpaz M
    Hematol Oncol Clin North Am; 1998 Feb; 12(1):31-80. PubMed ID: 9523225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic myeloid leukemia].
    Hochhaus A
    Dtsch Med Wochenschr; 2011 Oct; 136(40):2007-10. PubMed ID: 21960328
    [No Abstract]   [Full Text] [Related]  

  • 3. Homoharringtonine effective in CML patients.
    Hitt E
    Lancet Oncol; 2002 May; 3(5):259. PubMed ID: 12067785
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of myelogenous leukemia: current status and investigational options.
    Kantarjian HM; O'Brien S; Anderlini P; Talpaz M
    Blood; 1996 Apr; 87(8):3069-81. PubMed ID: 8605319
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
    Ezaki K
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():279-84. PubMed ID: 10895166
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous transplantation therapy for chronic myelogenous leukemia.
    Bhatia R; Verfaillie CM; Miller JS; McGlave PB
    Blood; 1997 Apr; 89(8):2623-34. PubMed ID: 9108379
    [No Abstract]   [Full Text] [Related]  

  • 7. Early treatment decisions with interferon-alfa therapy in early chronic-phase chronic myelogenous leukemia.
    Sacchi S; Kantarjian HM; Smith TL; O'Brien S; Pierce S; Kornblau S; Beran M; Keating MJ; Talpaz M
    J Clin Oncol; 1998 Mar; 16(3):882-9. PubMed ID: 9508169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
    O'Brien S; Talpaz M; Cortes J; Shan J; Giles FJ; Faderl S; Thomas D; Garcia-Manero G; Mallard S; Beth M; Koller C; Kornblau S; Andreeff M; Murgo A; Keating M; Kantarjian HM
    Cancer; 2002 Apr; 94(7):2024-32. PubMed ID: 11932905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific targeted therapy of chronic myelogenous leukemia with imatinib.
    Deininger MW; Druker BJ
    Pharmacol Rev; 2003 Sep; 55(3):401-23. PubMed ID: 12869662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
    Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H;
    Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML).
    Simonsson B; Kloke O; Stahel RA;
    Ann Oncol; 2005; 16 Suppl 1():i52-3. PubMed ID: 15888754
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive combination chemotherapy in treatment of CML.
    Lengfelder E; Hehlmann R
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S55-7. PubMed ID: 8769703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia: a review.
    Cortes JE; Talpaz M; Kantarjian H
    Am J Med; 1996 May; 100(5):555-70. PubMed ID: 8644769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon alfa versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group.
    J Natl Cancer Inst; 1997 Nov; 89(21):1616-20. PubMed ID: 9362160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.
    O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM
    Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stem cell transplantation for chronic myelogenous leukemia].
    Takayama N; Okamoto S
    Rinsho Ketsueki; 2000 Apr; 41(4):283-7. PubMed ID: 10846456
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigations.
    Opalka B; Kloke O; Wandl U; Becher R; Niederle N
    Haematol Blood Transfus; 1989; 32():134-8. PubMed ID: 2516494
    [No Abstract]   [Full Text] [Related]  

  • 18. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon therapy in chronic myelogenous leukemia.
    Guilhot F; Roy L; Guilhot J; Millot F
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.